Literature DB >> 28410711

Failure Modes and Effects Analysis of bilateral same-day cataract surgery.

Neal H Shorstein1, Carol Lucido2, James Carolan2, Liyan Liu2, Geraldine Slean2, Lisa J Herrinton2.   

Abstract

PURPOSE: To systematically analyze potential process failures related to bilateral same-day cataract surgery toward the goal of improving patient safety.
SETTING: Twenty-one Kaiser Permanente surgery centers, Northern California, USA.
DESIGN: Retrospective cohort study.
METHODS: Quality experts performed a Failure Modes and Effects Analysis (FMEA) that included an evaluation of sterile processing, pharmaceuticals, perioperative clinic and surgical center visits, and biometry. Potential failures in human factors and communication (modes) were identified. Rates of endophthalmitis, toxic anterior segment syndrome (TASS), and unintended intraocular lens (IOL) implantation were assessed in eyes having bilateral same-day surgery from 2010 through 2014.
RESULTS: The study comprised 4754 eyes. The analysis identified 15 significant potential failure modes. These included lapses in instrument processing and compounding errors of intracameral antibiotics that could lead to endophthalmitis or TASS, and ambiguous documentation of IOL selection by surgeons, which could lead to unintended IOL implantation. Of the study sample, 1 eye developed endophthalmitis, 1 eye had unintended IOL implantation (rates, 2 per 10 000; 95% confidence interval [CI], 0.1-12.0 per 10 000), and no eyes developed TASS (upper 95% CI, 8 per 10 000). Recommendations included improving oversight of cleaning and sterilization practices, separating lots of compounded drugs for each eye, and enhancing IOL verification procedures.
CONCLUSIONS: Potential failure modes and recommended actions in bilateral same-day cataract surgery were determined using an FMEA. These findings might help improve the reliability and safety of bilateral same-day cataract surgery based on current evidence and standards.
Copyright © 2017 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28410711      PMCID: PMC5419427          DOI: 10.1016/j.jcrs.2016.12.025

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  21 in total

1.  Simultaneous bilateral cataract surgery: Financial differences among nations and jurisdictions.

Authors:  Steve A Arshinoff; Sylvia H Chen
Journal:  J Cataract Refract Surg       Date:  2006-08       Impact factor: 3.351

2.  Simultaneous bilateral endophthalmitis after immediate sequential bilateral cataract surgery: what's the risk of functional blindness?

Authors:  Olivia Li; Venediktos Kapetanakis; Charles Claoué
Journal:  Am J Ophthalmol       Date:  2014-04       Impact factor: 5.258

3.  A cost and policy analysis comparing immediate sequential cataract surgery and delayed sequential cataract surgery from the physician perspective in the United States.

Authors:  Sean T Neel
Journal:  JAMA Ophthalmol       Date:  2014-11       Impact factor: 7.389

4.  Examining Wrong Eye Implant Adverse Events in the Veterans Health Administration With a Focus on Prevention: A Preliminary Report.

Authors:  Julia Neily; Amy Chomsky; James Orcutt; Douglas E Paull; Peter D Mills; Christina Gilbert; Robin R Hemphill; William Gunnar
Journal:  J Patient Saf       Date:  2018-03       Impact factor: 2.844

5.  Lessons learned: wrong intraocular lens.

Authors:  Oliver D Schein; James T Banta; Teresa C Chen; Scott Pritzker; Andrew P Schachat
Journal:  Ophthalmology       Date:  2012-06-14       Impact factor: 12.079

6.  Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin.

Authors:  Andre J Witkin; Anjali R Shah; Robert E Engstrom; Michelle M Kron-Gray; Caroline R Baumal; Mark W Johnson; Deborah I Witkin; John Leung; Thomas A Albini; Andrew A Moshfeghi; Ivan R Batlle; Lucia Sobrin; Dean Eliott
Journal:  Ophthalmology       Date:  2015-04-15       Impact factor: 12.079

7.  Simultaneous bilateral cataract surgery: economic analysis; Helsinki Simultaneous Bilateral Cataract Surgery Study Report 2.

Authors:  Tiina Leivo; Anna-Ulrika Sarikkola; Risto J Uusitalo; Timo Hellstedt; Sirje-Linda Ess; Tero Kivelä
Journal:  J Cataract Refract Surg       Date:  2011-06       Impact factor: 3.351

8.  Incidence of Acute Postoperative Endophthalmitis after Cataract Surgery: A Nationwide Study in France from 2005 to 2014.

Authors:  Catherine Creuzot-Garcher; Eric Benzenine; Anne-Sophie Mariet; Aurélie de Lazzer; Christophe Chiquet; Alain M Bron; Catherine Quantin
Journal:  Ophthalmology       Date:  2016-03-16       Impact factor: 12.079

9.  Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors.

Authors: 
Journal:  J Cataract Refract Surg       Date:  2007-06       Impact factor: 3.351

10.  Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery.

Authors:  Lisa J Herrinton; Neal H Shorstein; John F Paschal; Liyan Liu; Richard Contreras; Kevin L Winthrop; William J Chang; Ronald B Melles; Donald S Fong
Journal:  Ophthalmology       Date:  2015-10-14       Impact factor: 12.079

View more
  3 in total

Review 1.  Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts.

Authors:  Mor M Dickman; Lindsay S Spekreijse; Bjorn Winkens; Johannes Sag Schouten; Rob Wp Simons; Carmen D Dirksen; Rudy Mma Nuijts
Journal:  Cochrane Database Syst Rev       Date:  2022-04-25

2.  Immediately sequential bilateral cataract surgery (ISBCS) adapted protocol during COVID-19.

Authors:  Simrenjeet Sandhu; Daisy Liu; Pamela Mathura; Mathew Palakkamanil; Khaliq Kurji; Christopher J Rudnisky; Kam Kassiri
Journal:  Can J Ophthalmol       Date:  2021-11-09       Impact factor: 1.882

3.  Disruptive Innovation and Refractive IOLs: How the Game Will Change With Adjustable IOLs.

Authors:  David F Chang
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.